History & Expertise
Our company was founded in 2022, but it benefits from over 60 years of experience in Vector Control, and here in Africa, we are more than 50 passionate people dedicated to our partners.
At Envu, we are all pursuing the same goal: advancing healthy environments for everyone, everywhere, and this especially resonates with us. We help our partners save lives by preventing the bite.
Aside from the Vector Control solutions, we invest in partnerships with international organizations and foundations such as Goodbye Malaria, IVCC, United to Beat Malaria, and the United Nations Foundation. We also have close relationships with governments and institutions.
As involving the communities in the fight is also key, we also sponsor major initiatives such as PAMCA and Women In Vector Control, and we support the next generation of Malaria scientists.
Vector Control is a vital component of Malaria control and elimination strategies, as it is highly effective in preventing infection and reducing disease transmission.
Envu has a unique Vector Control portfolio that includes three different modes of action for resistance management. Currently, we have two products for Indoor Residual Spraying: Ficam® and Fludora® Fusion.
Fludora® Fusion is the first combination product used in Indoor Residual Spraying to delay resistance development. Since its launch in 2019, it has been used in more than 13 million households and has protected more than 90 million people.
Envu actively promotes and supports the safe use of Malaria Vector Control solutions through dedicated training sessions for pre- and post- spraying campaigns, but also by giving support to educate communities on the interventions that might be carried out in their environment. We strongly believe that spreading awareness of the Vector Control issue is key to helping them accept these products.
We are also committed to taking action in the R&D sector. As an Innovation company, Envu plays a key role in developing new solutions not only based on conventional chemistry but also on biorational active principles as well as new intervention methods